Related Experiment Video
Updated: Dec 18, 2025

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Dancing with reactive oxygen species generation and elimination in nanotheranostics for disease treatment
Zijian Zhou1, Kaiyuan Ni2, Hongzhang Deng1
1Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Reactive oxygen species (ROS) play important roles in cell signaling and tissue homeostasis, in which the level of ROS is critical through the equilibrium between ROS generating and eliminating events. A disruption of the balance leads to disease development either by a surplus or a dearth of ROS, which requires ROS-modulating strategies to overturn the defect for disease treatment. Over the past decade, there have been tremendous advances in nanomedicine centering ROS generation and/or elimination as major mechanisms to treat a variety of diseases. In this review, we will discuss the research achievements on two opposite approaches of ROS-generating and ROS-eliminating strategies for treating cancer and other related diseases. Importantly, we will highlight the conceptual and strategic advances of ROS-mediated immunomodulation, including macrophage polarization, immunogenic cell death and T cell activation, which are currently rising as one of the mainstreams of cancer therapy. At the end, the future challenges and opportunities of mediating ROS-based mechanisms are envisioned. In light of the pleiotropic roles of ROS in different diseases, we hope this review is timely to deliver a clear logic of designing principles on ROS generation and elimination for different disease treatments.
Insights
This review explores nanomedicine strategies for modulating reactive oxygen species (ROS) levels to treat diseases. It highlights ROS-generating and ROS-eliminating approaches, focusing on their role in cancer immunotherapy and future therapeutic design.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Cellular Biology
Background:
- Reactive oxygen species (ROS) are crucial for cell signaling and homeostasis.
- Imbalances in ROS levels contribute to disease pathogenesis.
- Nanomedicine offers novel strategies for modulating ROS.
Purpose of the Study:
- To review advancements in ROS-generating and ROS-eliminating nanomedicines for disease treatment.
- To highlight ROS-mediated immunomodulation in cancer therapy.
- To provide design principles for ROS-based therapeutic strategies.
Main Methods:
- Literature review of nanomedicine research focused on ROS modulation.
- Analysis of studies employing ROS-generating and ROS-eliminating strategies.
- Examination of ROS's role in immunomodulation (macrophage polarization, ICD, T cell activation).
Main Results:
- Significant progress in nanomedicine for ROS generation and elimination.
- Emerging success of ROS-mediated immunomodulation in cancer therapy.
- Demonstrated potential of ROS modulation for diverse disease treatments.
Conclusions:
- Nanomedicine provides powerful tools for balancing ROS levels in disease.
- ROS-mediated immunomodulation is a promising frontier in cancer treatment.
- Further research is needed to refine ROS-based therapeutic design principles.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Oxygen Requirements and Growth Patterns
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

